World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00008015
Date of registration: 16/04/2015
Prospective Registration: No
Primary sponsor: Departement für Sport, Bewegung und GesundheitUniversität Basel
Public title: Effect of Exercise training of different intensities on headache symptoms, physical fitness, cerebral capacity, endocrine function and pain perception in migraineurs
Scientific title: Effect of Exercise training of different intensities on headache symptoms, physical fitness, cerebral capacity, endocrine function and pain perception in migraineurs - MIGSPO
Date of first enrolment: 21/03/2014
Target sample size: 38
Recruitment status: Recruiting
URL:  http://drks.de/search/en/trial/DRKS00008015
Study type:  interventional
Study design:  Allocation: Randomized controlled study; Masking: Open (masking not used); Control: active; Assignment: parallel; Study design purpose: treatment  
Phase:  N/A
Countries of recruitment
Switzerland
Contacts
Name: Lars    Donath
Address:  Birsstrasse 320 B 4052 Basel Switzerland
Telephone: + 41 (0)61 377 87 38
Email: lars.donath@unibas.ch
Affiliation:  Departement für Sport, Bewegung und GesundheitUniversität Basel
Name: Gavin    Brupbacher
Address:  Birsstrasse 320 B 4052 Basel Switzerland
Telephone: +41 (0)61 377 87 51
Email: gavin.brupbacher@unibas.ch
Affiliation:  Departement für Sport, Bewegung und GesundheitUniversität Basel
Key inclusion & exclusion criteria
Inclusion criteria: Diagnosis of migraine by an experienced neurologist according to the International Classification of Headache Disorders, second edition (ICHD-II).
Exclusion criteria: (a) current medical preventive therapy (patients can be included if preventive medication was stopped at least 8 weeks before study entry), (b) other internal or neurological diseases, (c) regular exercise experiences (>2h of moderate to vigorous exercise per week) within the last 6 months, (d) patients with coronary heart disease, (e) chronic heart failure, (f) hypertension, (g) current use of antihypertensive medication or (h) peripheral arterial disease.

Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
G43.0
G43.1
Migraine without aura [common migraine]

G43.0
G43.1
Migraine with aura [classical migraine]
Intervention(s)
Group 1: High-intensity interval training: running training 2x/week for 12 weeks, with 4x4 minute intervals at 90% maximum heart rate with 3 minutes active recovery in between intervals at 70% maximum heart rate. The high-intensity interval training and the continuous training are isocaloric.
Group 2: Continuous aerobic training: running training 2/week for 12 weeks for 45 minutes at 70% maximum heart rate. The high-intensity interval training and the continuous training are isocaloric.
Group 3: Control group, i.e. no training intervention but other behaviour and medication as usual
Primary Outcome(s)
The number of days with headache will be measured using a headache diary during run-in, intervention and follow up.
Secondary Outcome(s)
Headache intensity and number of days with migraine is measured during run-in, intervention and follow up using a diary.
Headache associated disability (MIDAS questionnaire), cerebral (fMRI), endocrine (serum B-Endorphin), kognitive (Mini-Mental-State test, Trail Making Test, SWITCH Test, Tower of London Test, Regensburger Wortflüssigkeitstest, Frontal Assessment Batttery), and vascular function (retinal vessel diameter, SVA-T), cardio-respiratory fitness (spiroergometry), pain thresholds (thermode), and quality of life (WHO-QoL, BREF) are measured before and after the intervention phase.
Secondary ID(s)
Source(s) of Monetary Support
Universität Basel Vizerektorat Forschung Petersgraben 35, Postfach
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 13/08/2013
Contact:
Ethikkommission Nordwest- und Zentralschweiz (EKNZ) [Ethikkommission Nordwest- und Zentralschweiz]
Results
Results available:
Date Posted:
Date Completed:
URL: http://drks.de/search/en/trial/DRKS00008015#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history